Contact usLogin
MoleculeSalt Composition

You Searched

RENAD 4 MG INJECTION

RENAD 4 MG INJECTION

Molekule India Pvt. Ltd.

Vial of 2 ml

130

65 / ml
Doctor verified video thumbnail
All Our Medicines are
who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

Customers also bought

More About Renad

Manufacturer Address

Manufacturer Address

CRIMPAGE CORPORATION, 3RD FLOOR, PLOT NO. 57, STREET NO. 17, MIDC, MAROL, ANDHERI (EAST), MUMBAI MH 400093 IN , - , .

Checkout Editorial Policy

References

  • Westfall TC, Westfall DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 282-87

  • Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 139

  • Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 477

  • Teerlink JR, Sliwa Karen, Opie LH. Heart Failure. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 179-80

  • Drugs.com. Epinephrine Pregnancy and Breastfeeding Warnings (14 Mar. 2019)

  • Drugs and Lactation Database (LactMed) (19 Feb. 2020)

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.